CYTOCHROME-C (FE2+) AS A COMPETITIVE INHIBITOR OF NADPH-DEPENDENT REDUCTION OF CYTOCHROME-P450 LM2 - LOCATING PROTEIN PROTEIN-INTERACTION SITES IN MICROSOMAL ELECTRON CARRIERS

被引:20
作者
DAVYDOV, DR
DAROVSKY, BV
DEDINSKY, IR
KANAEVA, IP
BACHMANOVA, GI
BLINOV, VM
ARCHAKOV, AI
机构
[1] ACAD MED SCI MOSCOW,INST BIOL & MED CHEM,MOSCOW,USSR
[2] VECTOR RES & TRADE ASSOC,MOLEC BIOL RES INST,NOVOSIBIRSK,USSR
关键词
D O I
10.1016/0003-9861(92)90677-O
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The kinetics of NADPH-dependent reduction of cytochrome P450 LM2 in the soluble monomeric reconstituted system in the absence of any substrate is shown to be monophasic. We show that ferrous cytochrome c acts as a competitive inhibitor of the reduction. In the presence of 1 mm benzphetamine an additional extremely fast phase was observed. Under these conditions ferrous cytochrome c was found to be a competitive inhibitor of the slow phase of the reduction process, which accounted for 80% of the total reduction amplitude. Inhibition experiments yield a dissociation constant for the LM2-reductase complex of 3.0 ± 1.5 μm. This constant was the same both in the presence and in the absence of benzphetamine. Based on these data we conclude that cytochromes P450 and c bind to the same center on the NADPH-cytochrome P450 reductase molecule. Comparative analysis of the amino acid sequences reveals a detectable similarity between cytochrome c and cytochrome P450 LM2 at positions 68-87 and 121-145, respectively. In addition, a substantial similarity was shown for sequence fragments 204-224 of NADPH-cytochrome P450 reductase and 40-60 of cytochrome b5. Based on these findings a hypothesis for the location of the centers of intermolecular interactions on the molecules of cytochrome P450 LM2 and NADPH-cytochrome P450 reductase is proposed. © 1992.
引用
收藏
页码:304 / 313
页数:10
相关论文
共 46 条
  • [1] ARCHAKOV AI, 1992, CYTOCHROME P-450 : BIOCHEMISTRY AND BIOPHYSICS, P673
  • [2] ARCHAKOV AI, 1974, BIOCHEM J, V144, P1
  • [3] BACHMANOVA G, 1990, MICROSOMES DRUG OXID, P121
  • [4] BACHMANOVA GI, 1987, DRUG METABOLISM MOL, P419
  • [5] BAIROCH A, 1989, PROSITE DICT PROTEIN
  • [6] BERNHARDT R, 1988, BIOMED BIOCHIM ACTA, V47, P581
  • [7] BHASKARAN R, 1988, INT J PEPT PROT RES, V32, P241
  • [8] SECONDARY STRUCTURE PREDICTION - COMBINATION OF 3 DIFFERENT METHODS
    BIOU, V
    GIBRAT, JF
    LEVIN, JM
    ROBSON, B
    GARNIER, J
    [J]. PROTEIN ENGINEERING, 1988, 2 (03): : 185 - 191
  • [9] BOSTERLING B, 1982, J BIOL CHEM, V257, P4783
  • [10] BRODSKII L I, 1991, Biopolimery i Kletka, V7, P10